Cycloset Approved for Type 2 Diabetes - Health News - Health.com
Links shared publicly online about this topic.
- 2,060total visits
Cycloset Approved for Type 2 Diabetes - Health News - Health.com
View full resource at news.health.com
Tags: Diabetes, Blood Sugar, Type 2 Diabetes, Brain, Parkinson's Disease Medication, Drug, FDA, Parlodel
Most Recently Shared on May 8, 2009 at 12:34 am By:
Cycloset Approved for Type 2 Diabetes: Cycloset (bromocriptine), a drug that takes the novel approach of managin.. http://tinyurl.com/dm54c7
FDA Approves Linagliptin/Metformin Combo For Type 2 Diabetes : Family Practice News
familypracticenews.com — “FDA Approves Linagliptin/Metformin Combo For Type 2 Diabetes : Family Practice News” View full resource at familypracticenews.com
Most Recently Shared on January 31, 2012 at 6:18 pm By:
Damian McNamara Health Communicator
RT @FamilyPracNews: FDA Approves Linagliptin/Metformin Combo For Type 2 Diabetes http://t.co/4OQFJBli
Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes
news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin.” View full resource at news-medical.net
Most Recently Shared on January 31, 2012 at 12:29 pm By:
Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes: Boehringer Ingelheim P... http://t.co/QrEPkXXO
Bydureon Approved for Type 2 Diabetes - Drugs.com MedNews
drugs.com — “Bydureon (exenatide extended release), Amylin Pharmaceuticals long-acting version of the diabetes drug Byetta, has been approved by the U.S. Food and Drug Admin” View full resource at drugs.com
Most Recently Shared on January 28, 2012 at 3:17 am By:
Bydureon Approved for Type 2 Diabetes - http://t.co/qjuW2b7N
U.S. FDA approves Amylin's diabetes drug - Yahoo! News
news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - Amylin Pharmaceuticals Inc won U.S. approval on Friday for its Bydureon diabetes drug, a long-awaited victory for the company's most promising product. After two delays, the Food and Drug Administration approved once-weekly injectable Bydureon for treating adults with Type 2 diabetes, which is linked to poor diet and lack of exercise. Bydureon is a longer-acting form of Amylin's older Byetta treatment. Amylin shares jumped 16.6 percent to $14.16 in after ” View full resource at news.yahoo.com
Most Recently Shared on January 27, 2012 at 11:26 pm By:
U.S. FDA approves Amylin's diabetes drug: WASHINGTON (Reuters) - Amylin Pharmaceuticals Inc won U.S. approval on... http://t.co/5R3g6RBT
European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes
news-medical.net — “Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved ONGLYZA (saxagliptin) for use as a combination therapy with insulin (with or without metformin) to improve blood sugar (glycaemic) control in adult patients with type 2 diabetes.” View full resource at news-medical.net
Most Recently Shared on November 28, 2011 at 3:53 pm By:
Diabetes News: European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes: Bri... http://t.co/IjDwRuPp
Two-Drug Tablet for Diabetics with High Cholesterol Approved - Renal and Urology News
renalandurologynews.com — “The FDA has approved Juvisync, a combination prescription medication for patients with both type 2 diabetes and high cholesterol.” View full resource at renalandurologynews.com
Most Recently Shared on October 12, 2011 at 4:11 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Two-Drug Tablet for Diabetics with High Cholesterol Approved. http://t.co/AM8JSC4f #FDA #News #Drugs #Diabetes #Cholesterol
Lilly, Boehringer Diabetes Drug Gets European OK - Drugs.com MedNews
drugs.com — “From Associated Press (August 25, 2011) Drug makers Eli Lilly and Co. and Boehringer Ingelheim said Thursday European regulators have approved their type 2 diab” View full resource at drugs.com
Most Recently Shared on August 26, 2011 at 2:09 pm By:
Drugs and Devices OW OW Health
Lilly, Boehringer Diabetes Drug Gets European OK: From Associated Press (August 25, 2011) INDIANAPOLIS -- ... http://t.co/bW1yCIu #drug
Trajenta® (linagliptin) receives approval for the treatment of type 2 diabetes in Europe - News Press Release | PharmiWeb.com
pharmiweb.com — “Linagliptin is the only diabetes treatment to be approved once daily, one dosage strength for all adult patients without any need for dose adjustmentsIngelheim, Germany, 25.08.2011– Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) tod” View full resource at pharmiweb.com
Most Recently Shared on August 26, 2011 at 11:08 am By:
Press Release: Ingelheim, Germany, 25.08.2011– Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today ... http://t.co/9Jl5BxW
Congressman McCaul keeps “promise” meeting with Juvenile Diabetes Research Foundation in Katy - Your Houston News: News
yourhoustonnews.com — “Congressman Michael McCaul (R-TX 10) will have a “promise” meeting with Type 1 diabetics and their families in Katy to discuss legislation related to fighting the disease, including efforts to gain U.S. Food and Drug Administration approval of an artificial pancreas.” View full resource at yourhoustonnews.com
Most Recently Shared on August 17, 2011 at 8:06 pm By:
JDRF Advocacy Health Organization
@McCaulPressShop: Tx Rep McCaul 4 meeting w/ #JDRF Advocates on 8/19, luk fwd 2 telling u our story of ype 1 #diabetes http://t.co/6grgO1p
FDA Panel Says No to New Antidiabetes Agent - QualityPoint Technologies
qualitypointtech.net — “Cancer fears and lack of pharmacokinetic data have prompted an FDA advisory panel to nix approval of dapagliflozin, a first-in-class antidiabetic drug, to aid glycemic control in type 2 diabetes. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on July 20, 2011 at 3:00 am By:
FDA Panel Says No to New Antidiabetes Agent: Cancer fears and lack of pharmacokinetic data have prompted an FDA ad... http://bit.ly/nF6kB0
FDA Panel Says No to New Antidiabetes AgentFDA Panel Says No to New Antidiabetes Agent - QualityPoint Technologies
qualitypointtech.net — “Cancer fears and lack of pharmacokinetic data have prompted an FDA advisory panel to nix approval of dapagliflozin, a first-in-class antidiabetic drug, to aid glycemic control in type 2 diabetes. Medscape Medical News (Source: Medscape Today Headlines)MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.” View full resource at qualitypointtech.net
Most Recently Shared on July 20, 2011 at 2:45 am By:
FDA Panel Says No to New Antidiabetes AgentFDA Panel Says No to New Antidiabetes Agent: Cancer fears and lack of p... http://bit.ly/ozDptB
Medical News: ADA: Good Efficacy, Safety With Linagliptin - in Meeting Coverage, ADA from MedPage Today
medpagetoday.com — “SAN DIEGO -- The recently approved DPP-4 inhibitor linagliptin (Tradjenta) provided comparable control in type 2 diabetes to glimepiride (Amaryl) when added to metformin and cut the risk of cardiovasc” View full resource at medpagetoday.com
Most Recently Shared on June 28, 2011 at 6:06 pm By:
ADA: Good Efficacy, Safety With Linagliptin (CME/CE) http://bit.ly/jTsrWK
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on May 4, 2011 at 1:32 am By:
James Underberg Doctor, Internist, and Physician
FDA approves new drug for type 2 #diabetes http://bit.ly/mqu9Gv
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on May 3, 2011 at 5:12 pm By:
FDA approves new drug for type 2 diabetes: Linagliptin, which can be used alone or in combination with other the... http://bit.ly/jPApJQ
Tradjenta Approved for Type 2 Diabetes - MPR
empr.com — “Boehringer Ingelheim and Eli Lilly announced that the FDA has approved Tradjenta (linagliptin tablets), a dipeptidyl peptidase-4 (DPP-4) inhibitor, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.” View full resource at empr.com
Most Recently Shared on May 3, 2011 at 2:38 pm By:
MPR News: Tradjenta Approved for Type 2 Diabetes: Boehringer Ingelheim and Eli Lilly announced that the FDA has ... http://bit.ly/iYELgu
Advertisement
